My watch list  

351 Current news from the ressort manufacturing


You can refine your search further. Select from the filter options on the left to narrow down your results.

Evotec Neurosciences to licence NMDA receptor NR2B subunit selective antagonists from Roche


Evotec Neurosciences GmbH (ENS), a subsidiary of Evotec OAI AG announced that it has acquired from Roche an exclusive worldwide license to develop and market an extensive patent portfolio covering NMDA receptor NR2B subtype selective antagonists for the treatment of a variety of CNS disorders ...


Page 36 From 36
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE